Company: SXTPW
Filing Date: 2025-08-27
Form Type: DEF 14A
Source: 0001213900-25-080878
Chunk: 50

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-08-27
Form: DEF 14A
Chunk 50
---

as of December 31, 2024:

| 2022 Equity Incentive Plan:                                |     | Number of securities to be issued upon exercise or issuance of outstanding options, units, warrants and rights(1): |       |     | Weighted average exercise price of outstanding options, warrants and rights(1) : |        |     | Number of securities remaining available for future issuance(1) |         |
|:-----------------------------------------------------------|:----|:-------------------------------------------------------------------------------------------------------------------|------:|:----|:---------------------------------------------------------------------------------|-------:|:----|:----------------------------------------------------------------|--------:|
| Equity compensation plans approved by security holders     |     |                                                                                                                    | 4,437 |     | $                                                                                | 116.07 |     |                                                                 | 154,392 |
| Equity compensation plans not approved by security holders |     |                                                                                                                    |     — |     |                                                                                  |      — |     |                                                                 |       — |
| Total                                                      |     |                                                                                                                    | 4,437 |     | $                                                                                | 116.07 |     |                                                                 | 154,392 |

| (1) | Balances presented as of December 31, 2024 |

<div align='center'>The Board recommends that you vote “FOR” the approval to increase the total number of authorized shares
under the 2022 Equity Incentive Plan by 250,000 shares.

29

PROPOSAL 3</div>

TO APPROVE AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO EFFECT A REVERSE STOCK SPLIT OF OUR COMMON STOCK AT A REVERSE STOCK SPLIT RATIO RANGING FROM 1:3 TO 1:10, INCLUSIVE, AS DETERMINED BY THE BOARD IN ITS SOLE DISCRETION (Item 3 on the Proxy Card)

Our stockholders are being asked to approve an
amendment to our Certificate of Incorporation to effect a reverse stock split of our common stock at a reverse stock split ratio ranging
from 1:3 to 1:10, inclusive, as may be determined at the appropriate time by the Board, in its sole discretion (the “Reverse Stock
Split”). This means that once approved by the stockholders, the Board will be able to decide whether and when to effect the Reverse
Stock Split without further action from the stockholders.

The effectiveness of this amendment or the abandonment
thereof, notwithstanding stockholder approval, will be determined by the Board, at its sole option, following